Analysts Estimate Report : What to Look Out for Catalent (NYSE:CTLT)

0
124

Earnings results for Catalent (NYSE:CTLT)

Catalent, Inc. is expected* to report earnings on 08/31/2020 before market open. The report will be for the fiscal Quarter ending Jun 2020. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.81. The reported EPS for the same quarter last year was $0.65.

Analyst Opinion on Catalent (NYSE:CTLT)

8 Wall Street analysts have issued ratings and price targets for Catalent in the last 12 months. Their average twelve-month price target is $85.71, predicting that the stock has a possible downside of 2.22%. The high price target for CTLT is $105.00 and the low price target for CTLT is $62.00. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus rating of “Buy.”

Catalent has received a consensus rating of Buy. The company’s average rating score is 2.88, and is based on 7 buy ratings, 1 hold rating, and no sell ratings. According to analysts’ consensus price target of $85.71, Catalent has a forecasted downside of 2.2% from its current price of $87.66. Catalent has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Dividend Strength: Catalent (NYSE:CTLT)

Catalent does not currently pay a dividend. Catalent does not have a long track record of dividend growth.

Insiders buying/selling: Catalent (NYSE:CTLT)

In the past three months, Catalent insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,973,213.00 in company stock. Only 1.30% of the stock of Catalent is held by insiders.

Earnings and Valuation of Catalent (NYSE:CTLT

Earnings for Catalent are expected to grow by 1.10% in the coming year, from $1.82 to $1.84 per share. The P/E ratio of Catalent is 125.23, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.60. The P/E ratio of Catalent is 125.23, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.59. Catalent has a PEG Ratio of 3.66. PEG Ratios above 1 indicate that a company could be overvalued. Catalent has a P/B Ratio of 7.60. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here